Stock Price, News, Quote and Profile of CHARLES RIVER LABORATORIES(NYSE:CRL) stock

CHARLES RIVER LABORATORIES

NYSE:CRL (12/27/2024, 8:12:45 PM)

After market: 186.16 0 (0%)

186.16

-0.49 (-0.26%)

Chartmill TA Rating

Chartmill Setup Rating

Sector

GICS SectorHealth Care

GICS IndustryLife Sciences Tools & Services

GICS SubIndustryLife Sciences Tools & Services

Chartmill FA Rating

Valuation

Growth

Profitability

Health

Dividend

Chartmill High Growth Momentum

EPS Q2Q%-4.78%

Sales Q2Q%-1.64%

CRS20.76

6 Month-9.88%

Overview

Earnings (Last)11-06 2024-11-06/bmo

Earnings (Next)02-12 2025-02-12/amc

Ins Owners0.81%

Inst Owners102.9%

Market Cap9.52B

Shares51.14M

PE18.4

Fwd PE17.98

Dividend YieldN/A

Analysts66.4

Short Float %4.3%

Short Ratio3.14

IPO06-23 2000-06-23

Stock Screener Links

New York Stock Exchange, Inc. Stock Screener

Find more stocks on New York Stock Exchange, Inc.

GICS Sector Stock Screener

Find competitors from the same sector on the USA

GICS Industry Stock Screener

Find competitors from the same industry on the USA

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Best Technical Competitors Stock Screener

Find the competitors with the best technical ratings on the USA

Best Technical Setups Competitors Stock Screener

Find the competitors with the best technical and setup ratings on the USA

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA

Company Profile

Charles River Laboratories International, Inc. engages in providing products and services to help pharmaceutical and biotechnology companies. The company is headquartered in Wilmington, Massachusetts and currently employs 20,000 full-time employees. The company went IPO on 2000-06-23. The firm's Research Models and Services segment is comprised of three businesses that provide foundational tools that enables its clients to discover new molecules: Research Models, Research Model Services, and Cell Solutions. Its Discovery and Safety Assessment segment provides regulated and non-regulated DSA services to support the research, development, and regulatory-required safety testing of potential new drugs, including therapeutic discovery and optimization plus in vitro and in vivo studies, laboratory support services, and strategic non-clinical consulting and program management to support product development. Its Manufacturing Solutions segment includes Microbial Solutions and Biologics Solutions.

Company Info

CHARLES RIVER LABORATORIES

251 Ballardvale St

Wilmington MASSACHUSETTS 01887

P: 17812226000

CEO: James C. Foster

Employees: 21100

Website: https://www.criver.com/

CRL News

10 days ago - Market News VideoInteresting CRL Put And Call Options For August 2025

16 days ago - ChartmillWhich S&P500 stocks are gapping on Friday?

Looking for the S&P500 stocks that are experiencing notable gaps on Friday? Find out which stocks are gapping up and gapping down in the S&P500 index during today's session.